Actinium Pharmaceuticals, Inc.
ATNM
$1.24
$0.010.81%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 505.66% | 65.35% | 10.70% | 55.64% | 39.42% |
| Total Depreciation and Amortization | 18.14% | 7.32% | 0.98% | 1.98% | 7.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17,806.60% | -99.88% | -99.17% | -91.85% | -85.66% |
| Change in Net Operating Assets | 43.87% | 19.02% | 185.97% | 22.46% | -40.32% |
| Cash from Operations | 3.95% | 22.50% | 8.03% | 47.18% | 32.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | -50.00% | -50.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.33% | -50.00% | 0.00% | -104.54% | -100.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.86% | 22.60% | 6.33% | 11.38% | -372.20% |